Severe and fulminant hepatitis of indeterminate etiology in a Japanese center

Keiichi Fujiwara(Chiba University), Osamu Yokosuka(Chiba University), Tatsuo Kanda(Niigata Prefectural Niigata Minami High School), Makoto Arai(Chiba University), Masayuki Nakano(Nihon University), Shigeto Oda(Chiba University), Yutaka Yonemitsu(Chiba University), Yoshihiro Fukuda(Chiba University), Shin Yasui
Hepatology Research
January 12, 2015
10.1111/hepr.12483
Cited by 17

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma.A study of 57 autopsy-proven cases
|Cancer|1977|262